Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: ZD1839 in combination with docetaxel
Sponsor: NSABP Foundation Inc
Collaborators: AstraZeneca